0.1200CAD0.00%Mkt Cap: 6.53M CADP/E: —Last update: 2026-05-26
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap6.53M CAD
Enterprise Value5.43M CAD
Revenue (TTM)4.02M CAD
Gross Profit2.40M CAD
Net Income (TTM)94.38K CAD
Revenue/Share0.0890 CAD
Last Price0.1200 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-20.16
EV/Revenue1.35
P/S1.62
P/B1.82
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.11004% of range0.3400
52W High0.3400 CAD
52W Low0.1100 CAD
Profitability
Gross Margin52.86%
Oper. Margin-59.27%
EBITDA Margin-6.69%
Profit Margin2.08%
ROE2.62%
ROA2.13%
Growth
Revenue Growth-44.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-62.35K CAD
CapEx (TTM)471.52K CAD
FCF Margin-20.66%
FCF Yield-12.73%
Net Debt-1.16M CAD
Net Debt/EBITDA4.29
Balance Sheet
Debt/Equity0.04
Current Ratio3.28
Quick Ratio2.76
Book Value/Sh0.0660 CAD
Cash/Share0.0240 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.44M
Float31.86M
Insiders41.38%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short372
Short (prev mo.)687
Technical
SMA 500.1828 (-34.4%)
SMA 2000.2230 (-46.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)50.05K
Avg Vol (10d)138.76K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—